An investigation on behalf of investors in Teligent Inc (NASDAQ:TLGT) shares over potential wrongdoing at Teligent Inc was announced and NASDAQ:TLGT stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 01/19/2017 -- An investigation on behalf of investors in shares of Teligent Inc (NASDAQ:TLGT) was announced over potential breaches of fiduciary duties by certain officers and directors.
Investors who purchased shares of Teligent Inc (NASDAQ:TLGT) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.
The investigation by a law firm concerns whether certain Teligent Inc officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Buena, Nj based Teligent, Inc., formerly IGI Laboratories, Inc., is a specialty generic pharmaceutical company. Teligent Inc reported that its annual Total Revenue rose from $33.74 million in 2014 to $44.25 million in 2015 and that its Net Income increased from $5.25 million in 2014 to $6.67 million in 2015. Shares of Teligent Inc (NASDAQ:TLGT) reached in 2015 as high as $11.52 per share.
On January 18, 2017, NASDAQ:TLGT shares closed at $6.78 per share.
Those who purchased shares of Teligent Inc have certain options and should contact the Shareholders Foundation.